YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
[FDA Headquarters] The Trump administration on Tuesday appointed the acting heads of the FDA units overseeing drugs, vaccines, and tobacco to permanent positions weeks after nominating White House advisor Heidi Overton as the agency's next…
Wall Street's major averages ended lower on Friday as global technology stocks declined, led by semiconductors and the debut of Moonshot AI's Kimi-K3, which dragged down investor sentiment. The benchmark S&P 500 fell 1%, while the tech-hea…
Check out the companies making the biggest moves in midday trading: Abbott Laboratories – The maker of Ensure nutrition shakes jumped almost 11%. Abbott raised its full-year guidance for adjusted earnings, forecasting a range of $5.45 to $…
Investing.com -- Shares of psychedelic drug developers are surging premarket on Thursday after Eli Lilly announced a definitive agreement to acquire AtaiBeckley Inc., validating the sector and lifting sentiment across the space. AtaiBeckle…
Pipette dropping liquid into a test tube ©Adobe Stock Images GH Research (NASDAQ:GHRS) shares climbed around 12% in premarket trading on Thursday after reports that Eli Lilly (NYSE:LLY) is in discussions to acquire psychedelic drug develop…
An obscure psychedelic is drawing intense interest from the pharmaceutical industry. WSJ explores why companies are betting hundreds of millions of dollars on the therapeutic potential of a toad poison. View Comments
[Psychedelic Brain Therapy] wildpixel/iStock via Getty Images * A memorandum of understanding brokered Monday between HHS and the Veterans Administration could bode well for companies developing psychedelic-based drug treatments. * The MOU…
GH Research PLC (NASDAQ:GHRS) is one of the 10 Stocks That Have the Potential to Rise 1000%. On May 19, 2026, H.C. Wainwright lowered the firm’s price target on GH Research PLC (NASDAQ:GHRS) to $65 from $70 and maintained a Buy rating on t…
(RTTNews) - GH Research PLC (GHRS), a clinical-stage biopharmaceutical company, on Thursday announced Phase 2a results for GH001 in treating post-partum depression (PPD). Results were published in The Journal of Clinical Psychiatry. The co…
Key Takeaways; Cannabis Sector Organigram Reported its Second Quarter Fiscal 2026 Financial Results Village Farms Reported Q1 2026 Results Driven by Record International Export Sales Cronos Group Reported 2026 First Quarter Financial Resul…
* GH Research press release [https://seekingalpha.com/pr/20514971-gh-research-reports-first-quarter-2026-financial-results-and-provides-business-update] (GHRS [https://seekingalpha.com/symbol/GHRS]): Q1 GAAP EPS of -$0.31. * Cash, cash equ…
Compass Pathways, the developer of synthetic psilocybin, announced it had received a government voucher. Continue Reading
Psychedelic drugmakers just got a jolt that Wall Street couldn't ignore. After President Donald Trump signed an executive order (1) aimed at fast-tracking research and access to psychedelic therapies as a form of mental-health treatment, i…
Moneywise and Yahoo Finance LLC may earn commission or revenue through links in the content below. Psychedelics — once largely confined to the fringes of medicine and culture — are now drawing attention at the highest levels of government.…
Compass Pathways stock surged Monday after President Donald Trump signed an executive order tied to psychedelic drugs. Continue Reading
Health care stocks declined late Monday afternoon, with the NYSE Health Care Index down 1.1% and the PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscription plan is required to access premium n…
This article first appeared on GuruFocus. Markets are opening the week on a shaky footing as geopolitical tensions flare up, but if you look closer, individual stocks are moving sharply on their own stories. On the upside, the action is pr…
(RTTNews) - GH Research PLC (GHRS) has expressed strong support for the recent White House Executive Order aimed at accelerating medical treatments for serious mental illness. The company stated that the directive underscores the urgent ne…
AtaiBeckley and Compass Pathways are two drugmakers developing psychedelic treatments for depression. Continue Reading
Yahoo Finance's Julie Hyman and Brooke DiPalma takes a closer look at some of Monday morning's trending tickers and stories. Marvell (MRVL) stock is surging on reports that the company is in talks with Google (GOOG, GOOGL) to develop artif…
[Heart Health Concept] Eoneren/E+ via Getty Images Psychedelic stocks surged in premarket trading on Monday after President Donald Trump signed an executive order on Saturday to dramatically accelerate research into, and expand patient acc…
[Binary Code and stock market Data overlay for Financial Technology and Exchange] Stock index futures dipped lower Monday morning as renewed U.S.-Iran geopolitical tensions rattled global risk sentiment and drove oil prices higher. Here ar…
US stocks fell on Monday after a chaotic weekend of events reignited US-Iran tensions, putting peace talks at risk and leaving investors bracing for more uncertainty. The S&P 500 (^GSPC) shed 0.1%, while the tech-heavy Nasdaq Composite (^I…
[President Trump Signs Executive Order At The White House] Tasos Katopodis/Getty Images News President Donald Trump on Saturday signed an executive order to expedite access to research and treatments based on psychedelic drugs, a move tha…
Catch up on the top industries and stocks that were impacted, or were predicted to be impacted, by the comments, actions and policies of President Donald Trump with this daily recap compiled by The Fly. Claim 30% Off TipRanks Unlock hedge…
GH Research PLC (NASDAQ:GHRS) is among the best psychedelic stocks to buy in 2026. The company is advancing efforts to develop psychedelic medicines targeting conditions like depression, bipolar II disorder, and other psychiatric and neuro…
GH Research PLC (NASDAQ:GHRS) is among the 7 Most Promising Psychedelic Stocks According to Hedge Funds.RBC Capital Cite GH Research PLC's (GHRS) Long-Term Sales Potential Following Psychedelics Symposium GH Research PLC (NASDAQ:GHRS) is p…
The S&P 500 Index ($SPX) (SPY) on Monday closed up +0.64%, the Dow Jones Industrials Index ($DOWI) (DIA) closed up +1.23%, and the Nasdaq 100 Index ($IUXX) (QQQ) closed up +0.77%. March E-mini S&P futures (ESH26) rose +0.64%, and March E-m…
The S&P 500 Index ($SPX) (SPY) on Monday closed up +0.64%, the Dow Jones Industrials Index ($DOWI) (DIA) closed up +1.23%, and the Nasdaq 100 Index ($IUXX) (QQQ) closed up +0.77%. March E-mini S&P futures (ESH26) rose +0.64%, and March E-m…
The S&P 500 Index ($SPX) (SPY) today is up +0.72%, the Dow Jones Industrials Index ($DOWI) (DIA) is up +1.32%, and the Nasdaq 100 Index ($IUXX) (QQQ) is up +1.04%. March E-mini S&P futures (ESH26) are up +0.72%, and March E-mini Nasdaq fut…
The S&P 500 Index ($SPX) (SPY) today is up +0.54%, the Dow Jones Industrials Index ($DOWI) (DIA) is up +0.99%, and the Nasdaq 100 Index ($IUXX) (QQQ) is up +0.78%. March E-mini S&P futures (ESH26) are up +0.58%, and March E-mini Nasdaq fut…
The S&P 500 Index ($SPX) (SPY) today is up +0.72%, the Dow Jones Industrials Index ($DOWI) (DIA) is up +1.32%, and the Nasdaq 100 Index ($IUXX) (QQQ) is up +1.04%. March E-mini S&P futures (ESH26) are up +0.72%, and March E-mini Nasdaq fut…
The S&P 500 Index ($SPX) (SPY) today is up +0.54%, the Dow Jones Industrials Index ($DOWI) (DIA) is up +0.99%, and the Nasdaq 100 Index ($IUXX) (QQQ) is up +0.78%. March E-mini S&P futures (ESH26) are up +0.58%, and March E-mini Nasdaq fut…
Biotech stock GH Research catapulted Monday after the FDA gave it the go-ahead to resume testing its depression drug. Continue Reading
(RTTNews) - GH Research PLC (GHRS) announced the FDA has lifted the clinical hold on its Investigational New Drug Application for GH001. GH Research said the clearance enables U.S. subject enrollment and progresses the company toward align…
(RTTNews) - Biotech names dominated the after-hours session on Friday, with several companies posting notable gains despite limited news catalysts. GH Research PLC (GHRS) surged the most, climbing 22.36% to $16.20, up $2.96. The sharp move…